Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

@inproceedings{Macdonald2013HelpingOD,
  title={Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders},
  author={Kai Macdonald and David Feifel},
  booktitle={Front. Neurosci.},
  year={2013}
}
Concerns regarding a drought in psychopharmacology have risen from many quarters. From one perspective, the wellspring of bedrock medications for anxiety disorders, depression, and schizophrenia was serendipitously discovered over 30 year ago, the swell of pharmaceutical investment in drug discovery has receded, and the pipeline's flow of medications with unique mechanisms of action (i.e., glutamatergic agents, CRF antagonists) has slowed to a trickle. Might oxytocin (OT)-based therapeutics be… CONTINUE READING